Promising news about ETBX-011

Options
coloCan
coloCan CSN Member Posts: 1,944 Member
in Colorectal Cancer #1

http://online.wsj.com/article/PR-CO-20130506-904075.html

www.dailyfinance.com/2013/05/06/etubics-platform-generates-solid-immune-response-i/

 

Comments

  • Goldie1
    Goldie1 Member Posts: 264 Member
    #2
    Thanks...

    for posting this!  

    Ellen

  • renw
    renw Member Posts: 282 Member
    #3
    The article sounds good, but

    The article sounds good, but when you dig deeper, there was disease progression in 93.5% of patients taking part in the trials and ony 6.5% achieved stable disease, with no full remissions. Still a step in the right direction.

    The 50% or so 12 month survival is also hard to quantify without a control group.

Discussion Boards